No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
HK Stock MarketDetailed Quotes
01093 CSPC PHARMA
- 5.770
- -0.090-1.54%
Market Closed Apr 19 16:08 CST
68.79BMarket Cap10.61P/E (TTM)
5.820High5.650Low60.34MVolume5.790Open5.860Pre Close346.37MTurnover0.51%Turnover Ratio10.61P/E (Static)11.92BShares8.01052wk High1.88P/B68.79BFloat Cap5.20052wk Low0.25Dividend TTM11.92BShs Float12.999Historical High0.210Dividend LFY2.90%Amplitude-1.499Historical Low5.740Avg Price2000Lot Size4.33%Div YieldTTM3.64%Div Yield LFY
Intraday
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
CSPC Group (01093.HK) spent HK$34.5693 million to buy back 6 million shares on April 19
Gelonghui, April 19 | Shiyao Group (01093.HK) announced that on April 19, it spent HK$34.5693 million to repurchase 6 million shares, with a repurchase price of HK$5.66-5.82 per share.
Some Confidence Is Lacking In CSPC Pharmaceutical Group Limited's (HKG:1093) P/E
It's not a stretch to say that CSPC Pharmaceutical Group Limited's (HKG:1093) price-to-earnings (or "P/E") ratio of 10.9x right now seems quite "middle-of-the-road" compared to the market in Hong Kon
CSPC Group (01093) spent about HK$294.427 million to buy back 5 million shares on April 18
CSPC Group (01093) announced that the company spent approximately 294.427 million on April 18, 2024...
CSPC Group (01093) spent HK$349.292 million to buy back 6 million shares on April 17
Shiyao Group (01093) announced that on April 17, 2024, the company spent 349.292 million...
CSPC Group (01093.HK) spent HK$29.082 million to buy back 5 million shares on April 16
Gelonghui, April 16, 丨 Shiyao Group (01093.HK) announced that it spent HK$29.082 million to buy back 5 million shares on April 16.
CSPC Group (01093): A total of 19.5 million new shares were allotted to management grantees on April 15
Shiyao Group (01093) issued an announcement. On the date of this announcement, the conditions for the ownership of the first batch of share purchase rights have been fulfilled. At 2...
Comments
CSPC Pharmaceutical Group insiders' transactions over the last year indicate alignment with shareholders and optimism for the future. However, no insider trading occurred in the last quarter.
One CSPC Pharmaceutical Group Insider Raised Their Stake In The Previous Year 1
ColumnsHBM gets health boost from drug licensing deals
HBM gets health boost from drug licensing deals
December 22, 2023
2142.HK
1.56
(-2.5%)
The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer
Key Takeaways:
Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion
HBM Holdin...
December 22, 2023
2142.HK
1.56
(-2.5%)
The biopharma company has marked out a path to profitability by licensing its drug expertise and antibody platforms to partners such as Pfizer
Key Takeaways:
Nona Biosciences, a subsidiary of HBM Holdings, has struck a licensing-out deal with a Pfizer-owned biotech for an initial sum of $53 million and milestone payments of up to $1.05 billion
HBM Holdin...
HSI Opens 62 pts Lower as CN Developers Autos Fall; ; Oils Weaken
$Hang Seng Index(800000.HK$ dropped 62 points or 0.4% to open at 16,311 this morning (13th). $Hang Seng China Enterprises Index(800100.HK$ fell 24 points or 0.4% to 5,589. $Hang Seng TECH Index(800700.HK$ slid 26 points or 0.7% to 3,703.
The Central Economic Work Conference proposed to meet reasonable financing needs of real estate enterprises of different ownerships equally. Chinese developers rose this morning before dropping yesterday (12th). $LONGFOR GROUP(00960.HK$ and ...
The Central Economic Work Conference proposed to meet reasonable financing needs of real estate enterprises of different ownerships equally. Chinese developers rose this morning before dropping yesterday (12th). $LONGFOR GROUP(00960.HK$ and ...
2
1
The EPS uptick implies the share price fall could be due to previous overvaluation. Metrics besides dividends and revenue trend might better account for the price changes. Despite recent share price rise, the company has experienced major performance losses over the last five years.
Read more
Analysis
Price Target
No Data
Heat List
HK
Overall
Symbol
Latest Price
%Chg